University Hospital of North Durham is an acute care hospital built to replace the older Dryburn Hospital on the same site. It is managed by the County Durham and Darlington NHS Foundation Trust.

There are 523 beds in University Hospital of North Durham.

During the past decade, University Hospital of North Durham conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital of North Durham" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Medical Research Council" with 3 trials sponsored, "Abbott Diabetes Care" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Cancer Research UK" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of North Durham" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Action Medical Research" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "BUPA Foundation" with 1 trials as a collaborator and "Berry Consultants" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of North Durham" are "Breast Cancer" (3 trials), "Lung Cancer" (3 trials), "Metastatic Cancer" (3 trials), "Atrial Fibrillation" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "University Hospital of North Durham" in a lesser frequency.

Most popular intervention types in "University Hospital of North Durham" are "Drug" (20 trials), "Procedure" (6 trials), "Biological" (3 trials), "Radiation" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Docetaxel" (2 trials), "Fulvestrant" (2 trials), "Metformin" (2 trials) and "adjuvant therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of North Durham" are 22 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital of North Durham". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in University Hospital of North Durham, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of North Durham, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".